New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
05:53 EDTBBRY, AZNStocks with implied volatility movement; AZN BBRY
Stocks with implied volatility movement; AstraZeneca (AZN) 44, BlackBerry (BBRY) 53 according to iVolatility.
News For AZN;BBRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 17, 2014
09:30 EDTBBRYBlackBerry upgraded to Buy from Hold at BGC Financial
Subscribe for More Information
December 16, 2014
07:02 EDTBBRYVodafone to use loan to buy $750M of BlackBerry offerings, Globe and Mail says
Canada has agreed to lend $850M to Vodafone (VOD), which will use $750M of the funds to buy products and services from BlackBerry (BBRY), according to Globe and Mail. Reference Link
December 15, 2014
12:43 EDTBBRYBlackBerry short squeeze possible after launch, earnings, Goldman says
Shares of BlackBerrry (BBRY) could undergo a short squeeze this week, driven by the launch of the company's new BlackBerry Classic smartphone and the company's earnings conference call, Goldman Sachs wrote in a note to investors today. WHAT'S NEW: The launch of the Classic on Wednesday, along with BlackBerry's earnings conference call on Friday, could generate a short squeeze in BlackBerry's stock, Goldman analyst Simona Jankowski wrote. BlackBerry's Q3 earnings per share should be "largely in-line" with the consensus outlook, as higher hardware revenues should be more than offset by a decline in legacy service revenues, the analyst stated. However, the company's EPS for its quarter ended in February should beat expectations, driven by the launch of the Classic, Jankowski forecast. Still, she kept a Neutral rating on the stock. WHAT'S NOTABLE: According to Jankowski, the short interest in BlackBerry shares has risen to 21%. PRICE ACTION: In early afternoon trading, BlackBerry fell 1.7% to $9.67. The stock is off its low for the day of $9.40. BlackBerry shares have dropped about 12% over the last three months.
10:37 EDTBBRYBlackBerry could undergo short squeeze this week, says Goldman
Subscribe for More Information
07:36 EDTBBRYBlackBerry December volatility elevated into Q3 and outlook
Subscribe for More Information
07:33 EDTAZNAdvaxis announces FDA acceptance of INDA to commence clinical trials of ADXS-HPV
Subscribe for More Information
December 11, 2014
16:03 EDTAZNAmgen, AstraZeneca to present results from Phase 3 plaque psoriasis study
Subscribe for More Information
13:19 EDTBBRYMicrosoft dropped by Ford for in-car sync system, Re/code reports
Ford's (F) Sync 3 in-car entertainment and mapping system will use a version of BlackBerry's (BBRY) QNX operating system, replacing Microsoft (MSFT) technology that had been used in the prior two versions, Re/code reports. The QNX-powered system adds more features, including a capacitive touch screen and the ability to get software updates over Wi-Fi. Ford said in a statement that its "hardware and software decisions were based on identifying the technology that would best meet the expectations for performance by our customers." Reference Link
09:59 EDTBBRYBlackBerry December volatility increases into Q3 and outlook
Subscribe for More Information
07:28 EDTAZNCBI to hold a summit
2nd Specialty Data Optimization Summit is being held in Philadelphia on December 11.
December 9, 2014
09:10 EDTAZNARIAD takeover rumors rekindled, Independent says
Subscribe for More Information
08:50 EDTBBRYBlackBerry CEO says China entry won't be rushed, won't include takeover
BlackBerry (BBRY) Executive Chairman and CEO John Chen, in a post to his LinkedIn account entitled "Don't Believe The Hype," stated that he has recently I’ve been advised to capitalize on Kim Kardashian’s pronouncements that BlackBerry phones are her “heart and soul,” or talk up plans to enter the China market, "however preliminary they are today." Chen said BlackBerry's focus right now is on extending its security foundation with new solutions for the enterprise and that it "cannot and will not" chase sensationalism. "As for China, rest assured that we are developing a well-thought out plan that will take into account many factors, including timing and our long-term strategy. It won’t be rushed because it’s exciting or turned away from because of security concerns. And it won’t include a takeover," Chen wrote in his post. Reference Link
08:02 EDTAZNMoventig approved in EU for opioid-induced constipation
Nektar (NKTR) reported partner AstraZeneca (AZN) announced that MOVENTIG has been granted Marketing Authorisation by the European Commission for the treatment of opioid-induced constipation in adult patients who have had an inadequate response to laxative. MOVENTIG is the first once-daily oral peripherally-acting mu-opioid receptor antagonist to be approved in the European Union.
07:44 EDTAZNAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
December 8, 2014
07:05 EDTAZNInnocoll appoints Tony Zook as CEO
Innocoll AG (INNL) announced that Tony Zook, formerly executive vice president, Global Commercial Operations, at AstraZeneca (AZN), has been appointed CEO effectively immediately. Michael Myers, will continue with the company as head of Portfolio Operations.
December 5, 2014
10:18 EDTBBRYBlackBerry calls active on renewed takeover chatter
Subscribe for More Information
09:49 EDTAZNUBS European pharmaceuticals analysts holds analyst/industry conference call
Subscribe for More Information
09:44 EDTBBRYRumor: BlackBerry moves up on renewed takeover chatter
Subscribe for More Information
December 4, 2014
12:46 EDTBBRYBlackBerry CEO says Western nations would block China offer, Bloomberg says
Subscribe for More Information
08:45 EDTAZNAbbVie price target raised to $80 from $72 at Jefferies
Jefferies raised its price target for AbbVie shares to $80 while calling the company one of its top five global pharma picks for 2015. The firm's top U.S. pick is Pfizer (PFE) and its top Europe pick is Novartis (NVS). Bayer (BAYRY) and AstraZeneca (AZN) round out the top five. Jefferies thinks AbbVie's "strong momentum" will continue into the first half of 2015 and keeps a Buy rating on the name.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use